ダイト(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4577/E24187 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2017/11/24 | 日証協 | 45,550株 | -63.9% | 20,864株 | +1204% | 39,337株 | -1.01% | 83,900株 | +2793.1% |
2017/11/17 | 日証協 | 126,168株 | +0.24% | 1,600株 | -33.33% | 39,737株 | -1% | 2,900株 | -35.56% |
2017/11/10 | 日証協 | 125,868株 | -0.79% | 2,400株 | +200% | 40,137株 | -4.97% | 4,500株 | +32.35% |
2017/11/02 | 日証協 | 126,868株 | +7.35% | 800株 | -92.98% | 42,237株 | +2.18% | 3,400株 | +183.33% |
2017/10/27 | 日証協 | 118,180株 | -31.2% | 11,388株 | +207.78% | 41,337株 | -57.14% | 1,200株 | -68.42% |
2017/10/20 | 日証協 | 171,780株 | -1.2% | 3,700株 | -55.38% | 96,437株 | +1.58% | 3,800株 | -13.64% |
2017/10/13 | 日証協 | 173,873株 | -3.55% | 8,293株 | +276.95% | 94,937株 | -41.02% | 4,400株 | -73.78% |
2017/10/06 | 日証協 | 180,280株 | -6.09% | 2,200株 | -98.42% | 160,964株 | -19.56% | 16,780株 | -89.21% |
2017/09/29 | 日証協 | 191,980株 | -55.11% | 139,280株 | +259.7% | 200,114株 | -45.33% | 155,507株 | +2404.14% |
2017/09/22 | 日証協 | 427,710株 | -12.59% | 38,721株 | +780.02% | 366,067株 | -23.57% | 6,210株 | +45.2% |
2017/09/15 | 日証協 | 489,300株 | -0.2% | 4,400株 | -71.43% | 478,947株 | -0.46% | 4,277株 | -80.58% |
2017/09/08 | 日証協 | 490,300株 | +1.5% | 15,400株 | -30.22% | 481,170株 | +2.5% | 22,023株 | -25.54% |
2017/09/01 | 日証協 | 483,070株 | +4.06% | 22,070株 | -5.68% | 469,457株 | +6.58% | 29,576株 | +35.42% |
2017/08/25 | 日証協 | 464,207株 | +4.88% | 23,400株 | -16.45% | 440,481株 | -0.56% | 21,840株 | -54.02% |
2017/08/18 | 日証協 | 442,607株 | +10.16% | 28,007株 | +48.97% | 442,941株 | +4.07% | 47,500株 | +1879.17% |
2017/08/10 | 日証協 | 401,800株 | -1.08% | 18,800株 | -83.77% | 425,634株 | -3.09% | 2,400株 | -92.76% |
2017/08/04 | 日証協 | 406,200株 | +11.84% | 115,807株 | +18.9% | 439,224株 | +3.96% | 33,143株 | -25.35% |
2017/07/28 | 日証協 | 363,200株 | +17.74% | 97,400株 | +24.31% | 422,481株 | +10.03% | 44,400株 | -20.88% |
2017/07/21 | 日証協 | 308,480株 | +11.58% | 78,350株 | +449.25% | 383,957株 | +2.22% | 56,116株 | +292.42% |
※株式分割は考慮していませんのでご注意ください。
Page Top